Bath & Body Works, Inc. reported net sales of $1.577 billion for the third quarter ended October 31, 2026, reflecting a 1.0% decline from $1.594 billion in the prior-year period. Diluted earnings per share decreased to $0.19 for the quarter, down from $0.37 a year earlier. Adjusted diluted earnings per share were $0.26, excluding $13 million in pre-tax costs tied to business transformation initiatives and a $5 million pre-tax loss on the extinguishment of debt.
The Board of Directors has approved a new share repurchase program authorizing the purchase of up to $500 million in outstanding common stock. The program may begin following the completion of the company’s existing January 2025 repurchase plan.
Bath & Body Works updated its full-year 2026 net sales guidance to a projected decline of between 3.4% and 2.1% compared with $7.291 billion in fiscal 2025. The company also revised its full-year reported diluted earnings per share outlook to between $3.09 and $3.29, while maintaining its adjusted diluted earnings per share guidance of $2.60 to $2.80. For the fourth quarter of 2026, the company forecasts a net sales decline of between 5.5% and 2.0% compared with $2.724 billion in the prior-year period, with diluted earnings per share expected to range from $1.41 to $1.61.
Also Read
- Gold Prices Dip in Pakistan: 24K Tola at Rs395,236, 10-Gram Rate Rs338,851
- US and Venezuela Reestablish Military Ties Nearly a Year After Maduro’s Capture
- Israeli Mosque Torched as Opposition Leaders Accuse Netanyahu of Fueling Tensions
- James Cleverly Secures Conservative Nomination for London Mayor Race

